University of Plymouth has launched Vaccine Group, a vaccine developer based on research by Michael Jarvis, associate professor in virology and immunology.

Roivant Sciences, which is developing a range of drugs through various subsidiaries, has secured $1.1bn in a round led by the $93bn Vision Fund.

SoftBank China and Legend Capital both participated in a round that the gastrointestinal cancer diagnostics device developer will use to expand its R&D activities.

CWRU spinout Neuros Medical has raised $20m in a series AA round backed by Osage University Partners.

Taikang Life Insurance and Lilly Ventures Asia have contributed to a $59.7m round for Hangzhou Just Biotherapeutics, a Chinese spinout of US-based Just Biotherapeutics.

Neuromodulation device developer Neuros Medical has raised $20m in a series AA round backed by existing investor Boston Scientific .

China Life Insurance has participated in the medical clinic franchise's series D round, which is made up of almost equal debt and equity portions.

The pharmaceutical company's acquisition of Novartis-backed IFM Therapeutics, consisting of $300m upfront and up to $2bn in milestone payments, is its fourth purchase of a CVC-backed company in under four years.

Employee benefits platform Limelight Health secured $7m in a MassMutual Ventures-led round that included Axa Strategic Ventures and Wanxiang Healthcare Investments.